<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR106">
 <label>106.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Liu</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Yue</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Peng</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Guo</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Ji</surname>
    <given-names>Y</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Design, synthesis and pharmacological evaluation of 2-(thiazol-2-amino)-4-arylaminopyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors</article-title>
  <source>Eur J Medicinal Chem</source>
  <year>2014</year>
  <volume>86</volume>
  <fpage>438</fpage>
  <lpage>48</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ejmech.2014.09.003</pub-id>
 </element-citation>
</ref>
